HIV and tuberculosis co-infection in East Asia and the Pacific from 1990 to 2017: Results from the Global Burden of Disease Study 2017

Keyphrases

• Age-standardized Rate 9%
• AIDS/HIV 27%
• Co-infection 36%
• Drug Resistance 9%
• Drug-susceptible Tuberculosis 9%
• East Asia 100%
• Extensive Drug Resistance 9%
• Extensively Drug-resistant Tuberculosis 9%
• Global Burden of Disease Study 100%
• High Morbidity 9%
• High Mortality 9%
• HIV-infected Patients 100%
• HIV-TB 9%
• HIV/tuberculosis 18%
• Incidence Rate 27%
• Incidence/prevalence 27%
• Infection Type 18%
• Joinpoint Regression 9%
• MDR Tuberculosis 36%
• Mortality Rate 18%
• Multidrug-resistant Tuberculosis (MDR-TB) 45%
• Mycobacterium Tuberculosis (M. tb) 18%
• Overall Trend 9%
• Periodic Surveillance 9%
• Prevalence Rate 36%
• Prevalent Cases 9%
• Regression Modeling 9%
• Resistance Type 9%
• Resource Allocation 9%
• Trends in Incidence 9%
• Trends in Mortality 9%
• Trends in Prevalence 9%
• Tuberculosis Coinfection 100%
• Tuberculosis multidrug-resistant 9%
• XDR-tuberculosis 54%

Medicine and Dentistry

• Drug Resistance 12%
• Drug Resistant Tuberculosis 6%
• Global Disease Burden 100%
• HIV/AIDS 18%
• Human Immunodeficiency Virus 100%
• Mixed Infection 100%
• Morbidity 12%
• Mortality Rate 12%
• Multidrug Resistant Tuberculosis 6%
• Prevalence 37%
• Tuberculosis 100%

Immunology and Microbiology

• Coinfection 100%
• Disease Burden 100%
• Drug Resistance 14%
• HIV/AIDS 21%
• Human Immunodeficiency Virus 100%
• Morbidity 14%
• Mortality Rate 14%
• Multi-Drug-Resistant Tuberculosis 7%
• Prevalence 14%
• Prevalence Rate 28%